CompletedNCT00122070
Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
It focuses on personality disorders and currently lists study information in the United States.
Personality disorders, Borderline personalityDrugFrom 18 Years to 55 Years
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Cherry Hill, United StatesSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
Study information
Study start dateMay 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00122070
- Official title
- Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
Recruitment & locations
CompletedCherry Hill
Registry details
Registry conditions (original wording)
Borderline Personality Disorder
Questions about this study
Who is behind this study?
The study sponsor is University of Medicine and Dentistry of New Jersey, a university.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine Fumarate.
Who was this study for?
Listed age limits: 18 years to 55 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT02507206
A D1 Agonist For Working Memory
This study is completed. It focuses on personality disorders and currently lists study information in the United States.
CompletedNCT04566601
A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder
This study is completed in the United States, in Australia, in France, .... It focuses on Personality disorders.
CompletedNCT04100096
A study of Brexpiprazole in the Treatment of Borderline Personality Disorder
This study is completed. It focuses on personality disorders and currently lists study information in Spain, Ukraine, and the United States.